News & Updates

RELIFE, part of the leading Italian Pharmaceutical Company in the world, the Menarini Group, is set to bring a revolutionary approach to dermatology and aesthetic medicine treatments with the new Definisse™ range of facial fillers. The Definisse™ range of hyaluronic acid (HA) fillers boasts a novel, hi-tech stable and elastic 3D matrix developed using innovative EXcellent Three-dimensional Reticulation (XTR™) Technology, allowing good volumizing capability and providing predictable, long-lasting, and safe results. The filler range is now available in India, Singapore, Thailand, and the Philippines, and is set to launch in Malaysia and Indonesia in 2024. The Definisse™ filler range will strengthen Menarini’s existing dermatology and aesthetic portfolio in Asia.

Treatment with the investigational, topical pan-JAK inhibitor delgocitinib cream led to significantly greater improvements in efficacy outcomes compared with the vehicle cream in moderate-to-severe chronic hand eczema (CHE) in the pivotal phase III DELTA 1 trial, offering a rational strategy for targeted therapy.

For adults undergoing surgery, melatonin appears to help reduce the likelihood of postoperative delirium, according to the results of a meta-analysis.

Growth hormone (GH), compared with catecholamines, appears to be a better facilitator for the change from glucose to fatty acid metabolism following SGLT2 inhibitor use during exercise, reveals a study.

Adolescents and young adults who undergo vertical sleeve gastrectomy (VSG) experiences progressive changes in bone health over 2 years and are prone to skeletal fragility, suggests a study.

In Singapore, the COVID-19 pandemic and lockdown measures affected parents’ lives and family dynamics, leading to mental health decline, according to a survey.

A phase II nonrandomized trial of trabectedin in combination with radiotherapy for the treatment of myxoid liposarcoma has failed to meet its endpoint, although this treatment combination appears to be well tolerated in patients.